Octavius Pharma provides comprehensive pharmaceutical formulation development services, including pre-formulation studies, formulation development, analytical method development, method validation, stability studies, pilot batch manufacturing, manufacturing scale-up, technology transfer, and regulatory documentation support.
Octavius Pharma currently develops oral solid dosage forms and oral liquid formulations for pharmaceutical companies and healthcare brands.
Yes. Octavius Pharma performs pre-formulation studies such as API characterization, excipient compatibility studies, and formulation feasibility assessments to support successful product development.
Yes. Accelerated stability studies and long-term stability studies are conducted in accordance with ICH guidelines to evaluate product stability and support regulatory requirements.
Yes. Octavius Pharma supports pilot batch manufacturing and manufacturing scale-up to help ensure a smooth transition from formulation development to commercial manufacturing.
Yes. Regulatory support includes assistance with CTD preparation, validation documents, and product registration support where applicable.
Yes. Octavius Pharma supports technology transfer to facilitate the successful transfer of formulations from development to commercial manufacturing while maintaining product quality and process consistency.
Yes. Octavius Pharma collaborates with pharmaceutical companies, healthcare brands, and international partners by providing formulation development services along with access to WHO-GMP-certified manufacturing facilities, quality systems, and regulatory documentation support for global markets.
Yes. Octavius Pharma offers integrated solutions that include formulation development, technology transfer, pilot batch manufacturing, manufacturing scale-up, and contract manufacturing. This helps clients move efficiently from product development to commercial manufacturing.
A well-developed formulation helps ensure product quality, manufacturing consistency, regulatory compliance, and scalability during commercial production. By considering manufacturing requirements early in the development process, pharmaceutical companies can reduce development challenges and improve the transition to large-scale manufacturing.
GET IN TOUCH
For inquiries and collaboration opportunities, reach out to us today! Your gateway to innovative healthcare solutions awaits!
"*" indicates required fields